Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response-Reference-Cited by-同舟云学术

Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response

Published:2012-04-13 Issue:1 Volume:342 Page:150-162
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Burel Sebastien A.,Machemer Todd,Ragone Frank L.,Kato Hiroki,Cauntay Patrick,Greenlee Sarah,Salim Aneeza,Gaarde William A.,Hung Gene,Peralta Raechel,Freier Susan M.,Henry Scott P.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference59 articles.

1. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate

2. Selection of Molecular Structure and Delivery of RNA Oligonucleotides to Activate TLR7 versus TLR8 and to Induce High Amounts of IL-12p70 in Primary Human Monocytes

3. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity

4. Controlling the false discovery rate: a practical and powerful approach to multiple testing;Benjamini;J R Stat Soc B,1995

5. Bennett CF (2007) Pharmacological properties of 2′-O-methoxyethyl-modified oligonucleotides, in Antisense Drug Technologies, 2nd ed ( Crooke ST ed) pp 273–303, Taylor & Francis Group, LLC, Boca Raton, FL.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Discovery Perspectives of Antisense Oligonucleotides;Biomolecules & Therapeutics;2023-03-02

2. Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Through TLR9 in Human Burkitt Lymphoma B Bjab Cells;Nucleic Acid Therapeutics;2022-12-01

3. Early-Stage Identification and Avoidance of Antisense Oligonucleotides Causing Species-Specific Inflammatory Responses in Human Volunteer Peripheral Blood Mononuclear Cells;Nucleic Acid Therapeutics;2022-12-01

4. Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis;Journal of Lipid Research;2022-03

5. Antisense Oligonucleotide Technologies to Combat Obesity and Fatty Liver Disease;Frontiers in Physiology;2022-01-28